Navigation Links
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Date:5/16/2013

man von Willebrand Factor (vWF)

• Human Plasma-Derived Fibrinogen

• Recombinant Human Fibrinogen

• Human Plasma-Derived Factor XI

• Human Plasma-Derived Factor X

• Recombinant Human Factor X

• Human Plasma-Derived Factor XIII

• Recombinant Human Factor XIII

• Alternative Procoagulants & Adjuncts

• Human Plasma-Derived Prothrombin Complex Concentrates

• Gene Therapy of Hemophilia

• Topical Human Plasma-Derived Fibrinogen and Thrombin Products

• Topical Plasma-Derived Thrombin Products

• Topical Recombinant Human Factor II (Prothrombin)

• Alternative Topical Hemostats

 

7 ) Human Growth Hormone (hGH)

 

• 2012 Sales of Branded Somatropin Products in Regulated Markets

• 2012 Sales of Selected Somatropin Products in Non-Regulated Markets

• 1st Generation: Somatropin in Regulated Markets

 

• 1st Generation: Biosimilar Somatropin in Regulated Markets

• 2nd Generation: Injectable Somatropin in Slow-release Formulation in Regulated Markets

• 2nd Generation: Injectable Long-acting Somatropin in Regulated Markets

• 2nd Generation: Injection-Free Somatropin in Regulated Markets

 

• 1st Generation: Somatropin Products in Non-Regulated Markets

• 2nd Generation: Injectable Long-Acting Somatropin Products in Non-Regulated Markets

• Non-Medical, Legal Uses of Somatropin

 

8 ) FSH, hCG and LH - Assisted Reproductive Technology (ART)

• Urinary FSH-Containing Products: Menotropins

• Recombinant Menotropins

• 1st Generation Purified Human Urinary FSH

• 2nd Generation Recombinant Human FSH

• Biosimilar Recombinant Human FSH

• 2n
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cell Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
4. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
5. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
6. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
7. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
8. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
9. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
10. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
11. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... (PRWEB) March 26, 2015 WriteResult, a ... with researchers from Yale University’s School of Public Health ... study participants during a 4 month-long project. The goal ... providing low income families with free access to fresh ... and diet-related health concerns like high blood pressure, diabetes ...
(Date:3/25/2015)... 25, 2015 The surging prevalence ... have fuelled social media growth, with over 50% ... in social networking. Insurance companies are making use ... clients and promote a diversity of their services ... increasingly exploiting social networking services as part of ...
(Date:3/25/2015)... An increase of awareness related to benefits of ... nutrients, regulatory changes and concerns related to consumer safety ... natural astaxanthin over the past few years. Producers of ... to satisfy the rising demand. , The global ... in nutraceuticals, aqua feed, food and beverages and cosmetics) ...
(Date:3/25/2015)... LOUIS and the HAGUE, Netherlands ... of two-year results of LES Stimulation therapy for chronic ... the journal Surgery [ Surgery . ... efficacy of its minimally-invasive therapy. The ... average duration of 11 years and taking prescribed daily ...
Breaking Biology Technology:Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 2Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 3Social Media Role in Global Insurance Industry Examined by Timetric in New Market Research Report Published at MarketPublishers.com 2Social Media Role in Global Insurance Industry Examined by Timetric in New Market Research Report Published at MarketPublishers.com 3Global Astaxanthin Market to Reach Value of USD 1.1 billion by 2020, Expects Industry Experts in New Report Available at MarketPublishers.com 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3
... GeneLink BioSciences, Inc. (OTC Bulletin Board: ... announced that it ranked number 62 on Technology Fast ... fastest growing technology, media, telecommunications, life sciences and clean ... percentage of fiscal year growth during the period from ...
... -- DALLAS, October 25, 2010 ... ... lpUnit=,PRN,; --> ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... Oct. 22 Trius Therapeutics, Inc. (Nasdaq: TSRX ... at Trius Therapeutics, will present "Innovative Antibacterial Drugs by Design; ... event taking place on October 26, 2010 from 5:30-9:30 p.m. ... available at http://sdbn.org/october . About ...
Cached Biology Technology:GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloitte's 2010 Technology Fast 500™ 2MarketsandMarkets New Report - Global Ophthalmology Drugs & Devices Market 2MarketsandMarkets New Report - Global Ophthalmology Drugs & Devices Market 3MarketsandMarkets New Report - Global Ophthalmology Drugs & Devices Market 4MarketsandMarkets New Report - Global Ophthalmology Drugs & Devices Market 5MarketsandMarkets New Report - Global Ophthalmology Drugs & Devices Market 6MarketsandMarkets New Report - Global Ophthalmology Drugs & Devices Market 7MarketsandMarkets New Report - Global Ophthalmology Drugs & Devices Market 8MarketsandMarkets New Report - Global Ophthalmology Drugs & Devices Market 9
(Date:3/23/2015)... Conn. , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... new advertising campaign on CNBC television starting March 30 th ... will commence airing in New York ... Officer said: "We are excited about our new ad campaign ...
(Date:3/19/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, announces its biometric payment technology, the ... aired this week on Washington DC,s ... a segment "The Next Great Thing", host Laura Evans ... pay, and ,a really big breakthrough in mobile payment.,  ...
(Date:3/16/2015)... , March 16, 2015 ... Systems GmbH will present groundbreaking innovations in biometric ... Hanover, Germany .      (Photo: ... latest biometric innovation is well at the forefront: ... generation e-gate made in Germany ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3
... have traditionally been thought of as homogeneous ... single-cell observational techniques, like flow cytometry, microfluidics, ... the observation of individual microbes within populations. ... Biological Synthesis (NIMBioS) is now accepting applications ...
... stronger brain response to certain brain regions when receiving ... quit smoking four months after, a new study found. ... the importance of delivering individually tailored public health messages ... Chua, who led the study as a research assistant ...
... Researchers at The Forsyth Institute have made a significant ... scientific studies led by Anne Tanner, BDS, Ph.D., identified ... (cavities). This bacterium, Scardovia wiggsiae , was present ... caries when other known pathogens such as Streptococcus ...
Cached Biology News:Ecology of microbes focus of workshop 2Certain parts of the brain activated in people who heard tailored health messages and quit smoking 2Forsyth team gains new insight on childhood dental disease 2
... designed to rapidly and reliably amplify unknown ... Technology. APAgene provides hassle-free, ready-to use components, ... ingredients are provided in each kit. The ... gap filling, localized cloning of genomic DNA, ...
Protein YIPF6 (YIP1 family member 6). [Source:Uniprot/SWISSPROT;Acc:Q96EC8] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Collected from animals of U.S. origin.Collected from animals of U.S. origin. *Can be used in cell growth studies and immunoassays. *Sterility tested, * Mycoplasma tested upon request, *Endoto...
...
Biology Products: